Empowering Clinicians
With Evidence- based
Molecular Dianostics
OUR VISION
Affordable Genomics For All
OUR CORE VALUES: ·G·E·N·O·M·E·
- Growing with our Valued Partners in the medical fraternity.
- Empowering Clinicians with Evidence-based Molecular Diagnostics.
- Novel Technologies and Innovation.
- Optimising Efficiencies.
- Motivating Teamwork.
- Excellence in All We Do.
CGx STORY
Cytogenomix Sdn Bhd (“CGx”) was conceived from the Vision of two renowned Doctors (IVF Specialists) from Dubai who have interest to set up genetics laboratories in Malaysia following their successes in setting up the same in India and Dubai.
Joining hands with a Medical Geneticist from Maldives, a USM Professor and a Malaysian Chartered Accountant, CGx is now poised to become the leading genetics and genomics diagnostic laboratory in this Region that offers Affordable Genomics For All.
CGx mission is to empower Clinicians and other healthcare professionals with Evidence-based Molecular Diagnostics.
We are committed to continuous research and innovating new genomics diagnostic tests, bioinformatic solutions and technologies to the medical fraternity for better patient care.
We have the necessary technical medical-science expertise, business knowledge and experiences.
We are definitely not the usual start-up company that you can find!
OUR LABORATORIES
We are proud to be the largest Genomics Laboratory with over 9,000 sf space on the Penang Island.
We have invested in approximately RM3.0 mil to purchase the Lab equipment, instrument, accessories, tools and facilities; these enabled us to:
- Develop our own Laboratory Developed Tests (LDTs)
- Customise panels for specific diseases requested by the doctors; and
- Have the widest range of genomics diagnostic tests.
We are on track to achieve ISO 15189 certification during 2023 and aim to obtain CAP accreditation by early 2024.
Next investment (approximately RM500k) –
Microarray instrument for
the following tests:
- Prenatal, Postnatal - for chromosomal abnormality including Microdeletions
- Mental Impairment
- Development Delay
- Autistic Features
- Brain and other organ dysfunctions
- Uniparental disomy studies
- Gene expression studies
- Patients cytogenetically balanced chromosomal rearrangements and an abnormal phenotype (~30% of pt may be +ve)
